- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 675317, 8 pages
The Role of T-Cell Leukemia Translocation-Associated Gene Protein in Human Tumorigenesis and Osteoclastogenesis
Institute of Rheumatology, Tokyo Women's Medical University, 10-22 Kawada-cho, Shinjuku, Tokyo 162-0054, Japan
Received 1 August 2011; Accepted 29 September 2011
Academic Editor: Byoung S. Kwon
Copyright © 2012 Shigeru Kotake et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- N. J. Horwood, V. Kartsogiannis, J. M. W. Quinn, E. Romas, T. J. Martin, and M. T. Gillespie, “Activated T lymphocytes support osteoclast formation in vitro,” Biochemical and Biophysical Research Communications, vol. 265, no. 1, pp. 144–150, 1999.
- T. Kawai, T. Matsuyama, Y. Hosokawa et al., “B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease,” American Journal of Pathology, vol. 169, no. 3, pp. 987–998, 2006.
- K. Kobayashi, N. Takahashi, E. Jimi et al., “Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction,” Journal of Experimental Medicine, vol. 191, no. 2, pp. 275–285, 2000.
- S. Kotake, K. Sato, K. J. Kim et al., “Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation,” Journal of Bone and Mineral Research, vol. 11, no. 1, pp. 88–95, 1996.
- S. Kotake, N. Udagawa, N. Takahashi et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” Journal of Clinical Investigation, vol. 103, no. 9, pp. 1345–1352, 1999.
- S. Kotake, N. Udagawa, M. Hakoda et al., “Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients,” Arthritis and Rheumatism, vol. 44, no. 5, pp. 1003–1012, 2001.
- S. Kotake, Y. Nanke, M. Mogi et al., “IFN-γ-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL,” European Journal of Immunology, vol. 35, no. 11, pp. 3353–3363, 2005.
- H. Takayanagi, K. Ogasawara, S. Hida et al., “T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ,” Nature, vol. 408, no. 6812, pp. 600–605, 2000.
- T. Yago, Y. Nanke, M. Kawamoto et al., “IL-23 induces human osteoclastogenesis via IL-17 in vitro, and anti-IL-23 antibody attenuates collagen-induced arthritis in rats,” Arthritis Research and Therapy, vol. 9, no. 5, article R96, 2007.
- T. Yago, Y. Nanke, N. Ichikawa et al., “IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-α antibody: a novel mechanism of osteoclastogenesis by IL-17,” Journal of Cellular Biochemistry, vol. 108, no. 4, pp. 947–955, 2009.
- S. Kotake, Y. Nanke, M. Kawamoto et al., “T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis,” Bone, vol. 45, no. 4, pp. 627–639, 2009.
- S. Kotake, T. Yago, M. Kawamoto, and Y. Nanke, “The role of T-cell leukemia translocation-associated gene (TCTA) protein in human osteoclastogenesis,” Japanese Journal of Clinical Immunology, vol. 32, no. 6, pp. 466–471, 2009.
- P. D. Aplan, B. E. Johnson, E. Russell, D. S. Chervinsky, and I. R. Kirsch, “Cloning and characterization of TCTA, a gene located at the site of a t(1;3) translocation,” Cancer Research, vol. 55, no. 9, pp. 1917–1921, 1995.
- J. F. Rual, K. Venkatesan, T. Hao et al., “Towards a proteome-scale map of the human protein-protein interaction network,” Nature, vol. 437, no. 7062, pp. 1173–1178, 2005.
- C. Luxenburg, D. Geblinger, E. Klein et al., “The architecture of the adhesive apparatus of cultured osteoclasts: from podosome formation to sealing zone assembly,” PLoS ONE, vol. 2, no. 1, article e179, 2007.
- K. Fuller, B. Kirstein, and T. J. Chambers, “Regulation and enzymatic basis of bone resorption by human osteoclasts,” Clinical Science, vol. 112, no. 11-12, pp. 567–575, 2007.
- P. Sarrazin, J. A. Hackett, I. Fortier, M. A. Gallant, and A. J. De Brum-Fernandes, “Role of EP3 and EP4 prostaglandin receptors in reorganization of the cytoskeleton in mature human osteoclasts,” Journal of Rheumatology, vol. 31, no. 8, pp. 1598–1606, 2004.
- N. Takahashi, T. Akatsu, N. Udagawa et al., “Osteoblastic cells are involved in osteoclast formation,” Endocrinology, vol. 123, no. 5, pp. 2600–2602, 1988.
- N. Udagawa, N. Takahashi, T. Akatsu et al., “Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 18, pp. 7260–7264, 1990.
- T. Suda, N. Udagawa, I. Nakamura, C. Miyaura, and N. Takahashi, “Modulation of osteoclast differentiation by local factors,” Bone, vol. 17, no. 2, supplement, pp. 87S–91S, 1995.
- N. Udagawa, S. Kotake, N. Kamatani, N. Takahashi, and T. Suda, “The molecular mechanism of osteoclastogenesis in rheumatoid arthritis,” Arthritis Research, vol. 4, no. 5, pp. 281–289, 2002.
- J. Lam, C. A. Nelson, F. P. Ross, S. L. Teitelbaum, and D. H. Fremont, “Crystal structure of the TRANCE/RANKL cytokine reveals determinants of receptor-ligand specificity,” Journal of Clinical Investigation, vol. 108, no. 7, pp. 971–979, 2001.
- Y. Y. Kong, U. Feige, I. Sarosi et al., “Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand,” Nature, vol. 402, no. 6759, pp. 304–309, 1999.
- N. G. Testa, T. D. Allen, L. G. Lajtha, D. Onions, and O. Jarret, “Generation of osteoclasts in vitro,” Journal of Cell Science, vol. 47, pp. 127–137, 1981.
- K. J. Ibbotson, G. D. Roodman, L. M. McManus, and G. R. Mundy, “Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells,” Journal of Cell Biology, vol. 99, no. 2, pp. 471–480, 1984.
- B. R. MacDonald, N. Takahashi, L. M. McManus, J. Holahan, G. R. Mundy, and G. D. Roodman, “Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures,” Endocrinology, vol. 120, no. 6, pp. 2326–2336, 1987.
- N. Takahashi, H. Yamana, S. Yoshiki et al., “Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures,” Endocrinology, vol. 122, no. 4, pp. 1373–1382, 1988.
- G. Hattersley and T. J. Chambers, “Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures,” Endocrinology, vol. 125, no. 3, pp. 1606–1612, 1989.
- S. Shimizu, S. Shiozawa, K. Shiozawa, S. Imura, and T. Fujita, “Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 28, no. 1, pp. 25–31, 1985.
- S. Kotake, M. Higaki, K. Sato et al., “Detection of myeloid precursors (granulocyte/macrophage colony forming units) in the bone marrow adjacent to rheumatoid arthritis joints,” Journal of Rheumatology, vol. 19, no. 10, pp. 1511–1516, 1992.
- S. Kotake, H. R. Schumacher Jr., and R. L. Wilder, “A simple nested RT-PCR method for quantitation of the relative amounts of multiple cytokine mRNAs in small tissue samples,” Journal of Immunological Methods, vol. 199, no. 2, pp. 193–203, 1996.
- S. Kotake, H. R. Schumacher, C. H. Yarboro et al., “In vivo gene expression of type 1 and type 2 cytokines in synovial tissues from patients in early stages of rheumatoid, reactive, and undifferentiated arthritis,” Proceedings of the Association of American Physicians, vol. 109, no. 3, pp. 286–302, 1997.
- Y. Nanke, S. Kotake, T. Ninomiya, T. Furuya, H. Ozawa, and N. Kamatani, “Geranylgeranylacetone inhibits formation and function of human osteoclasts and prevents bone loss in tail-suspended rats and ovariectomized rats,” Calcified Tissue International, vol. 77, no. 6, pp. 376–385, 2005.
- Y. Nanke, M. Kawamoto, T. Yago, J. Chiba, H. Yamanaka, and S. Kotake, “Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis,” Modern Rheumatology, vol. 19, no. 4, pp. 379–383, 2009.
- S. Kotake, T. Yago, M. Kawamoto, and Y. Nanke, “Effects of NSAIDs on differentiation and function of human and murine osteoclasts—crucial “Human Osteoclastology”,” Pharmaceuticals, vol. 3, no. 5, pp. 1394–1410, 2010.
- S. Kotake, T. Yago, M. Kawamoto, and Y. Nanke, “The role of T-cell leukemia translocation-associated gene (TCTA) protein in human osteoclastogenesis,” in T-Cell Leukemia, O. Babusikova, Ed., InTech-Open Access Publisher, Rijeka, Croatia, 2011.
- C. Saginario, H. Sterling, C. Beckers et al., “MFR, a putative receptor mediating the fusion of macrophages,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6213–6223, 1998.
- S. J. Choi, N. Kurihara, Y. Oba, and G. D. Roodman, “Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its c-terminal fragment,” Journal of Bone and Mineral Research, vol. 16, no. 10, pp. 1804–1811, 2001.
- F. Ikeda, R. Nishimura, T. Matsubara et al., “Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-requlated osteoclast differentiation,” Journal of Clinical Investigation, vol. 114, no. 4, pp. 475–484, 2004.
- E. Jimi, K. Aoki, H. Saito et al., “Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo,” Nature Medicine, vol. 10, no. 6, pp. 617–624, 2004.
- T. Kukita, N. Wada, A. Kukita et al., “RANKL-induced DC-STAMP is essential for osteoclastogenesis,” Journal of Experimental Medicine, vol. 200, no. 7, pp. 941–946, 2004.
- T. Yi, H. J. Kim, J. Y. Cho et al., “Tetraspanin CD9 regulates osteoclastogenesis via regulation of p44/42 MAPK activity,” Biochemical and Biophysical Research Communications, vol. 347, no. 1, pp. 178–184, 2006.
- P. Lundberg, C. Koskinen, P. A. Baldock et al., “Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPα-interaction,” Biochemical and Biophysical Research Communications, vol. 352, no. 2, pp. 444–448, 2007.
- T. Yago, Y. Nanke, M. Kawamoto, et al., “Antibodies against CD47 expressed on monocytes in rheumatoid arthritis patients inhibits human osteoclastogenesis by blocking fusion of monocytes,” Arthritis and Rheumatism, vol. 50, supplement, p. 1394, 2006, abstract no. S354.
- G. Mbalaviele, H. Chen, B. F. Boyce, G. R. Mundy, and T. Yoneda, “The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow,” Journal of Clinical Investigation, vol. 95, no. 6, pp. 2757–2765, 1995.
- A. Vignery, “Osteoclasts and giant cells: macrophage-macrophage fusion mechanism,” International Journal of Experimental Pathology, vol. 81, no. 5, pp. 291–304, 2000.
- A. Vignery, “Macrophage fusion: the making of osteoclasts and giant cells,” Journal of Experimental Medicine, vol. 202, no. 3, pp. 337–340, 2005.
- E. Abe, H. Mocharla, T. Yamate, Y. Taguchi, and S. C. Manolagas, “Meltrin-α, a fusion protein involved in multinucleated giant cell and osteoclast formation,” Calcified Tissue International, vol. 64, no. 6, pp. 508–515, 1999.
- K. Suzuki, B. Zhu, S. R. Rittling et al., “Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts,” Journal of Bone and Mineral Research, vol. 17, no. 8, pp. 1486–1497, 2002.
- S. Kotake, Y. Nanke, T. Yago, M. Kawamoto, and H. Yamanaka, “Human osteoclastogenic T cells and human osteoclastology,” Arthritis and Rheumatism, vol. 60, no. 11, pp. 3158–3163, 2009.
- A. D. Johnston, “Pathology of metastatic tumors in bone,” Clinical Orthopaedics and Related Research, vol. 73, pp. 8–32, 1970.